Better Targeting
The medicine released in this early mouse trial interferes with blood coagulation. But, the possibility of many various forms of therapy being delivered straight into cancer cells is astounding.
This type of precision targeting will accelerate cancer treatment by leaps and bounds because the primary issue with standard treatment is that it damages all cells, not just cancer cells.
More precise targeting has the potential to significantly reduce cancer patients’ adverse effects, as well as keep inflammation at bay and the immune system strong.
